PSG
home page
 
PARKINSON STUDY GROUP PRESENTS:
STARTING A CLINICAL RESEARCH CAREER
CLUES FOR SUCCESS
Updated May 26, 2010
Monday, April 12, 2010
12:00-1:30 p.m.


The Strathcona Hotel
60 York Street, Toronto, Canada
York Street Café Room


The PSG Mentoring Committee is hosting a program entitled “Parkinson Study Group Presents: Starting a Clinical Research Career – Clues for Success” during the AAN Annual Meeting this year on Monday, April 12, 2010 from 12:00-1:30 p.m. in Toronto at The Strathcona Hotel (two blocks away from the main meeting venue). This lunch time program is designed specifically for early career investigators including neurology residents, fellows and those within 5 years of completing fellowship training and is provided at no charge to the participants. The objective is to provide a forum for discussion of methods, opportunities and obstacles for developing and a clinical research career and to familiarize the participants with the PSG. Topics will include identifying educational opportunities, selecting the right fellowship, negotiating a junior faculty position, and obtaining research funding. The role of mentoring and interactions with CTSAs will be covered.

Dr. Joel Perlmutter, Chair and Dr. Jon Stoessl, Co-chair of the PSG Mentoring Committee will facilitate the program. Dr. Wendy Galpern, Program Director in the Office of Clinical Research at NIH/NINDS, is our special guest. Please feel free to extend this invitation on to others who you know may be interested.

Advance registration is closed, but walk-ins are welcome!

The Strathcona Hotel Downtown Toronto is 2 blocks (approximately a 10 minute walk) from the Metro Toronto Convention Centre which is the main meeting venue.  Link to map of hotels: http://www.cmrhousing.com/aan_5i/map.aspx.

If you have any questions, please contact Roseanna Battista at: Roseanna.Battista@ctcc.rochester.edu or call 1-585-275-1642 (office).  Roseanna can be reached the day before or day of the meeting by cell at 1-585-749-8341.

We look forward to seeing you!

 

This meeting has been made possible through the Parkinson’s Disease Foundation’s
Advancing Parkinson’s Treatments Innovations Grant.

 

 

 
 
 

TOP OF PAGE